Thomvest contributes to Prometic's $61.7 mln fundraising
Laval, Québec biopharmaceutical company Prometic Life Sciences Inc (TSX: PLI) has raised $61.7 million in gross proceeds from two equity offerings. In the first, a bought deal equity offering, Prometic secured $53.1 million. In the second, a private placement, it obtained $8.6 million from a vehicle affiliated with Thomvest Asset Management, the investment firm of Peter Thomson. The latter deal's proceeds were used to reduce amounts owed on a Thomvest loan. Prometic is focused on developing therapeutics from its plasma-derived and small-molecule platforms.
6 July 2017•3 mins read
